Lack of Resident-Specific Dementia Care Plans Before Psychotropic Use
Summary
The facility failed to ensure resident-specific dementia care plans were developed and used before psychotropic medications were started or increased for four residents with dementia. For one resident with unspecified dementia and mood disturbance, the record showed moderate cognitive impairment, but the comprehensive care plan did not include a dementia care plan with potential behaviors or behavior interventions. Although orders were in place to monitor targeted behaviors, progress notes and the MAR documented no behaviors during the month, while Rexulti was initiated for agitation/anxiety and trazodone was increased for insomnia without documentation of the behaviors prompting those changes or interventions attempted beforehand. Later, haloperidol was ordered stat after the resident expressed suicidal ideation and distress about wanting to leave the facility, but the note lacked documentation of a further assessment of the suicidal ideation, a plan, or other interventions beyond contacting family. For another resident with moderate vascular dementia and agitation, the record included orders to monitor for a wide range of behaviors related to anxiety, aggression, hallucinations, paranoia, and delusions, but the MAR and progress notes repeatedly documented zero behaviors during multiple months. The resident’s care plans addressed incontinence, ADL deficits, and nutritional risk, and a later care plan noted the potential for physical behaviors after the resident became aggressive and hit another resident, but the interventions were generalized and did not include resident-specific dementia interventions to use before psychotropic medication was initiated or increased. The VP of Clinical stated dementia-related interventions should have been included in the care plans and could not find a resident-specific dementia care plan. A resident with Alzheimer’s disease and severe cognitive impairment also lacked a resident-specific dementia care plan. The care plan described resistive care, refusal of labs and showers, inappropriate behaviors, nighttime wakefulness, and delusional-type statements, but the interventions were generalized rather than individualized. The MAR documented agitation, anxiety, verbal aggression, and repetitive verbalizations on one shift and agitation on another, yet the record lacked documentation of interventions attempted or their effectiveness for at least one of those episodes. Lorazepam was increased after a behavior episode in which the resident was redirected with snacks and drinks, but the record did not document why the medication increase was needed when the intervention had been effective. A fourth resident with dementia and Parkinson’s disease had repeated episodes of agitation, delusions, aggression, refusal of medications, and other behaviors, and received one-time IM Haldol doses on multiple occasions, but the resident’s care plans lacked an individualized, person-centered dementia care plan. The record also showed Quetiapine use for dementia with mood disturbances, while the diagnosis list did not support the later documented indication of psychotic disorder with delusions due to a known physiological condition.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.